ESC 365 - Doctor Kazuma Oyama

Speaker illustration

Doctor Kazuma Oyama

Tohoku University, Sendai (Japan)

Member of:

Prediction of 10-year risk for recurrent atherosclerotic cardiovascular events in a secondary prevention population: Insights from CHART-2 and Suita studies in the Japanese population

Event: ESC Congress 2024

Topic: Scores

Session: Risk scores in different populations

Acute arterial events across all vascular territories in the FOURIER trial

Event: ESC Congress 2021 - The Digital Experience

Topic: Lipid-Lowering Agents

Session: Highlights from the Young on cutting edge therapy for lowering lipids

Influence of cardiovascular drugs on the efficacy and safety of dapagliflozin in patients with type 2 diabetes mellitus in the DECLARE-TIMI 58 trial

Event: ESC Congress 2021 - The Digital Experience

Topic: Antidiabetic Pharmacotherapy

Session: Congress committee e-posters choice in pharmacology and pharmacotherapy

Serial measurement of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in ENGAGE AF-TIMI 48

Event: ESC Congress 2020

Topic: Stroke in Atrial Fibrillation

Session: Young Investigator Award Session Thrombosis

Evidence for enhanced inflammation of coronary adventitia and perivascular adipose tissue in patients with vasospastic angina -A multi-modality imaging study-

Event: ESC Congress 2017

Topic: Inflammation and microcirculation

Session: Young Investigator Awards Session Coronary Pathophysiology and Microcirculation

Evidence for involvement of inflammatory changes of perivascular adipose tissue in the pathogenesis of DES-induced hyperconstricting responses in pigs in vivo -Impact of 18F-FDG PET imaging-

Event: ESC Congress 2016

Topic: Non-invasive coronary imaging

Session: Young Investigators Awards Session Coronary Pathophysiology and Microcirculation

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources